Cell Reports (Sep 2015)

MiR-93 Controls Adiposity via Inhibition of Sirt7 and Tbx3

  • Michele Cioffi,
  • Mireia Vallespinos-Serrano,
  • Sara M. Trabulo,
  • Pablo Jose Fernandez-Marcos,
  • Ashley N. Firment,
  • Berta N. Vazquez,
  • Catarina R. Vieira,
  • Francesca Mulero,
  • Juan A. Camara,
  • Ultan P. Cronin,
  • Manuel Perez,
  • Joaquim Soriano,
  • Beatriz G. Galvez,
  • Alvaro Castells-Garcia,
  • Verena Haage,
  • Deepak Raj,
  • Diego Megias,
  • Stephan Hahn,
  • Lourdes Serrano,
  • Anne Moon,
  • Alexandra Aicher,
  • Christopher Heeschen

DOI
https://doi.org/10.1016/j.celrep.2015.08.006
Journal volume & issue
Vol. 12, no. 10
pp. 1594 – 1605

Abstract

Read online

Conquering obesity has become a major socioeconomic challenge. Here, we show that reduced expression of the miR-25-93-106b cluster, or miR-93 alone, increases fat mass and, subsequently, insulin resistance. Mechanistically, we discovered an intricate interplay between enhanced adipocyte precursor turnover and increased adipogenesis. First, miR-93 controls Tbx3, thereby limiting self-renewal in early adipocyte precursors. Second, miR-93 inhibits the metabolic target Sirt7, which we identified as a major driver of in vivo adipogenesis via induction of differentiation and maturation of early adipocyte precursors. Using mouse parabiosis, obesity in mir-25-93-106b–/– mice could be rescued by restoring levels of circulating miRNA and subsequent inhibition of Tbx3 and Sirt7. Downregulation of miR-93 also occurred in obese ob/ob mice, and this phenocopy of mir-25-93-106b–/– was partially reversible with injection of miR-93 mimics. Our data establish miR-93 as a negative regulator of adipogenesis and a potential therapeutic option for obesity and the metabolic syndrome.